EE219 Lorlatinib as a First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Greece
| Autor: | Gourzoulidis, G., Zisimopoulou, O., Liavas, A., Tzanetakos, C. |
|---|---|
| Zdroj: | In Value in Health December 2023 26(12) Supplement:S93-S93 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect